Bifunctional Linchpins for Cysteine Cyclization and Radiometal Chelation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Peptides used as pharmaceuticals and radiopharmaceuticals often require modification to enhance their in vivo half-life, and existing methods for cyclization and radiometal chelation are limited in efficacy and versatility.

Innovation Solution

Development of bifunctional linchpins that selectively react with cysteine residues to induce cyclization and concurrently introduce a DOTAGA moiety for radiometal chelation, such as DOTAGALP1, or incorporate a SiFA-motif for silicon-acceptor chemistry to facilitate 18F-labeling, exemplified by SiFALP, enhancing peptide stability and radiolabeling options.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If peptides are modified to improve in vivo half-life, then stability is improved, but molecular complexity increases

Engineering Contradiction:
Improvepeptide stabilityVSAvoidmolecular complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent combines two separate functions (cyclization for stability improvement and radiometal chelation for imaging/therapy) into a single bifunctional linchpin molecule. This merging approach improves peptide stability through cyclization while simultaneously providing radiometal chelation capability, rather than requiring separate modifications that would increase molecular complexity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The bifunctional linchpin serves multiple functions: it acts as a cyclization agent to improve peptide stability, a radiometal chelator for imaging and therapy, and a linker to attach to cysteine residues. This multi-functionality reduces the need for multiple separate modifications, thereby improving stability without proportionally increasing molecular complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Manufacturing precision

If separate cyclization and radiometal chelation steps are used, then manufacturing precision is improved, but productivity decreases

Engineering Contradiction:
Improveconjugation precisionVSAvoidradiopharmaceutical production efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent merges the cyclization step and radiometal chelation step into a single simultaneous reaction using the bifunctional linchpin. This eliminates the need for sequential operations, thereby improving productivity while maintaining manufacturing precision through the designed reactivity of the linchpin with cysteine residues

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The bifunctional linchpin is pre-designed with both cyclization and chelation functionalities integrated. This preliminary preparation allows both functions to be executed in a single step during radiopharmaceutical synthesis, improving productivity without sacrificing the precision of cysteine-specific conjugation

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If multiple separate modifications are applied to peptides, then versatility is improved, but device complexity increases

Engineering Contradiction:
Improveradiopharmaceutical versatilityVSAvoidpeptide structure complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The bifunctional linchpin provides universal functionality for both cyclization and radiometal chelation in a single molecule. This versatility allows the same linchpin structure to be used across different peptide targets and radiometal isotopes, improving radiopharmaceutical versatility without requiring multiple different modification agents that would increase peptide structure complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The linchpin is designed with specific local functional groups: a maleimide or halogenated alkene moiety for cysteine-specific cyclization, and a DOTAGA or SiFA chelator for radiometal binding. This localized functional organization provides versatility for different applications while maintaining a relatively simple overall molecular structure compared to multiple separate modifications

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new bifunctional linchpins maintain peptide specificity for somatostatin receptor SSTR2, demonstrate high potency with Cu-containing chelates, and enable successful radiolabeling with metals like 67Cu, 68Ga, and 135La, improving peptide half-life and radiopharmaceutical performance.

Implementation Method 1

bifunctional linchpins that react selectively with cysteine residues to invoke cyclization while concurrently introducing a radiometal chelation ligand

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentUS20250270238A1A new bifunctional linchpin that reacts selectively with cysteine residues to invoke cyclization while concurrently introducing a dotaga moiety for radiometal chelation
Publication Date: 2025.08.28 THE GOVERNORS OF THE UNIV OF ALBERTA
  • US20250270238A1 patent drawing
  • US20250270238A1 patent drawing
  • US20250270238A1 patent drawing

AI summary

The present disclosure relates generally to new bifunctional linchpins that react selectively with cysteine residues to invoke cyclization while concurrently introducing a radiometal chelation ligand or silicon-based fluoride acceptor (SiFA) motif.